77 related articles for article (PubMed ID: 8064837)
1. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
[TBL] [Abstract][Full Text] [Related]
2. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
[TBL] [Abstract][Full Text] [Related]
3. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.
Raponi G; Lun MT; Lorino G; Nazzari C; Gaeta A; Mancini C; Filadoro F
J Antimicrob Chemother; 1993 Jan; 31(1):117-28. PubMed ID: 8444656
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
6. Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli.
Raponi G; Ghezzi MC; Lun MT; Bigotti G; Natali PG; Mancini C
J Med Microbiol; 2000 Mar; 49(3):253-260. PubMed ID: 10707945
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; Torensma R; Verhoef J
J Infect Dis; 1991 Jan; 163(1):122-7. PubMed ID: 1701816
[TBL] [Abstract][Full Text] [Related]
8. Characterization of murine monoclonal antibodies to Escherichia coli J5.
Miner KM; Manyak CL; Williams E; Jackson J; Jewell M; Gammon MT; Ehrenfreund C; Hayes E; Callahan LT; Zweerink H
Infect Immun; 1986 Apr; 52(1):56-62. PubMed ID: 3514463
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
Dunn DL; Bogard WC; Cerra FB
Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
[TBL] [Abstract][Full Text] [Related]
10. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
13. Immunization of mice with antibiotic treated Escherichia coli.
Raponi G; Nazzari G; Lun MT; Lorino G; Valentini T; Bronzini M; Gaeta A; Mancini C; Filadoro F
J Chemother; 1991 Jan; 3 Suppl 1():136-40. PubMed ID: 12041748
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
Oishi K; Koles NL; Guelde G; Pollack M
J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
[TBL] [Abstract][Full Text] [Related]
15. Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis.
Haralambieva I; Iankov I; Petrov D; Ivanova R; Kamarinchev B; Mitov I
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):99-106. PubMed ID: 11750161
[TBL] [Abstract][Full Text] [Related]
16. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
Sakulramrung R; Domingue GJ
J Infect Dis; 1985 Jun; 151(6):995-1004. PubMed ID: 3889175
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections.
Pere A; Leinonen M; Väisänen-Rhen V; Rhen M; Korhonen TK
J Gen Microbiol; 1985 Jul; 131(7):1705-11. PubMed ID: 2864387
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to avian Escherichia coli Iss.
Foley SL; Horne SM; Giddings CW; Gustad TR; Handegard ED; Robinson M; Nolan LK
Avian Dis; 2003; 47(1):79-86. PubMed ID: 12713161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
